Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: Analysis of Japanese patients in CheckMate 214 with extended follow-up

Yoshihiko Tomita, Tsunenori Kondo, Go Kimura, Takamitsu Inoue, Yoshiaki Wakumoto, Masahiro Yao, Takayuki Sugiyama, Mototsugu Oya, Yasuhisa Fujii, Wataru Obara, Robert J. Motzer, Hirotsugu Uemura

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Nivolumab plus ipilimumab versus sunitinib in previously untreated advanced renal-cell carcinoma: Analysis of Japanese patients in CheckMate 214 with extended follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences